Kinder Morgan, Inc. · KMI · FY2025 Q2 · Calendar Q3 2025
KMI: LNG, power demand and backlog support a constructive outlook
The supplied analysis supports a constructive but conditional view: resilient LNG and power demand, a growing backlog and fee-based projects may support earnings growth, while contract roll-off, tariffs and execution risks test that outlook.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about KMI FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior supplied quarter analysis, the backlog is described at $9.3 billion and management emphasized double-digit adjusted EBITDA and EPS growth, improved permitting, tax benefits and upgraded credit ratings. Guidance sentiment remained maintained, while concerns now include Permian rate erosion, project-FID timing and access to behind-the-meter data-center opportunities.
Guidance delta
Maintained; no change in guidance sentiment is identified in the supplied analysis.
Key takeaways
- Management described double-digit year-over-year growth in adjusted EBITDA and EPS.
- The project backlog increased to $9.3 billion, with LNG and power projects advancing.
- Management cited permitting improvements, tax benefits and upgraded credit ratings as supportive of cash flow and financing.
- The main debate is whether LNG and power demand can offset contract roll-off and project-execution risks.
Management priorities
- Advance Trident Phase 2 and Louisiana Line Texas Access projects.
- Deploy $500 million of KinderHawk capex to support lease-back contracts.
- Pursue Arizona projects, including the Copper State connector.
- Develop behind-the-meter data-center supply solutions with regulated utilities.
- Continue expanding NGPL infrastructure for power-plant service.
Follow KMI with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Sep 22, 2026 |
| Jefferies | Hold | Hold | Maintain | Sep 18, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Mar 30, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Mar 26, 2026 |
| Truist Securities | Hold | Hold | Maintain | Mar 24, 2026 |
| Stifel | Hold | Hold | Maintain | Mar 13, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Mar 3, 2026 |
| Freedom Broker | Hold | Sell | Upgrade | Jan 28, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jan 22, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 28, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 25, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jun 23, 2025 |
| UBS | Buy | Buy | Maintain | Jan 27, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 26, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Oct 11, 2024 |
| Argus Research | Buy | Hold | Upgrade | Jul 19, 2024 |
| Bernstein | Outperform | Market Perform | Upgrade | Mar 1, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | May 27, 2021 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 11, 2021 |
| SMBC Nikko | Outperform | Outperform | Maintain | Dec 3, 2020 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 9, 2020 |
| CFRA | Buy | Buy | Maintain | Apr 24, 2020 |
| PiperJaffray | Neutral | Neutral | Maintain | Dec 18, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Oct 17, 2019 |
| TD Securities | Buy | Buy | Maintain | Oct 2, 2019 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 30, 2019 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jun 17, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 20, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Mar 21, 2018 |
| Tudor Pickering | Hold | Accumulate | Downgrade | Jan 22, 2013 |
| Bank oferica | Underperform | Underperform | Maintain | Mar 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $31.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $36 | $31.68 | +13.1% | Sep 22, 2026 |
| RBC Capital | Elvira Scotto | $36 | $31.72 | +13.1% | Sep 22, 2026 |
| Morgan Stanley | Julien Dumoulin-Smith | $33 | $31.31 | +3.7% | Sep 17, 2026 |
| Stifel Nicolaus | Analyst unavailable | $35 | $31.41 | +10.0% | Sep 9, 2026 |
| Morgan Stanley | Devin McDermott | $38 | $31.82 | +19.4% | Jul 29, 2026 |
| Wells Fargo | Analyst unavailable | $36 | $32.49 | +13.1% | Jul 23, 2026 |
| UBS | Manav Gupta | $43 | $31.46 | +35.1% | Jun 15, 2026 |
| Scotiabank | Analyst unavailable | $32 | $34.07 | +0.6% | Mar 26, 2026 |
| Scotiabank | Analyst unavailable | $30 | $29.69 | -5.7% | Jan 23, 2026 |
| Morgan Stanley | Jason Gabelman | $35 | $29.53 | +10.0% | Jan 22, 2026 |
| Scotiabank | Analyst unavailable | $29 | $27.86 | -8.9% | Jan 16, 2026 |
| Morgan Stanley | Analyst unavailable | $29 | $26.89 | -8.9% | Dec 23, 2025 |
| UBS | Manav Gupta | $38 | $26.76 | +19.4% | Dec 12, 2025 |
| Morgan Stanley | Analyst unavailable | $30 | $28.14 | -5.7% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $27.67 | +0.6% | Sep 18, 2025 |
| Morgan Stanley | Jason Gabelman | $34 | $28.34 | +6.9% | Jul 7, 2025 |
| Morgan Stanley | Analyst unavailable | $31 | $27.14 | -2.6% | Mar 3, 2025 |
| Scotiabank | Brandon Bingham | $26 | $28.16 | -18.3% | Jan 10, 2025 |
| RBC Capital | Elvira Scotto | $26 | $24.74 | -18.3% | Oct 22, 2024 |
| Morgan Stanley | John MacKay | $26 | $24.82 | -18.3% | Oct 18, 2024 |
| Morgan Stanley | Stewart Glickman | $28 | $24.82 | -12.0% | Oct 17, 2024 |
| Roth Capital | John White | $30.5 | $24.93 | -4.1% | Oct 17, 2024 |
| Truist Financial | Neal Dingmann | $25 | $24.93 | -21.4% | Oct 17, 2024 |
| Wells Fargo | Michael Blum | $27 | $24.93 | -15.1% | Oct 17, 2024 |
| RBC Capital | Elvira Scotto | $24 | $24.86 | -24.6% | Oct 16, 2024 |
| Morgan Stanley | Gabriel Moreen | $25 | $24.38 | -21.4% | Oct 11, 2024 |
| Morgan Stanley | Neel Mitra | $27 | $23.72 | -15.1% | Oct 11, 2024 |
| RBC Capital | Elvira Scotto | $22 | $21.29 | -30.9% | Jul 30, 2024 |
| Morgan Stanley | Bill Selesky | $24 | $21.73 | -24.6% | Jul 19, 2024 |
| UBS | Brian Reynolds | $24 | $19.94 | -24.6% | Jun 12, 2024 |
| Wells Fargo | Michael Blum | $22 | $19.5 | -30.9% | Jun 4, 2024 |
| Morgan Stanley | Stewart Glickman | $22 | $19.4 | -30.9% | May 14, 2024 |
| Wells Fargo | Michael Blum | $18 | $18.21 | -43.4% | Apr 19, 2024 |
| Morgan Stanley | Linda Ezergailis | $21 | $18.24 | -34.0% | Apr 18, 2024 |
| Truist Financial | Neal Dingmann | $20 | $17.97 | -37.1% | Mar 25, 2024 |
| Goldman Sachs | John Mackay | $20 | $16.76 | -37.1% | Oct 10, 2023 |
| Citigroup | Spiro Dounis | $19 | $16.94 | -40.3% | Jul 10, 2023 |
| Barclays | Theresa Chen | $20 | $17.99 | -37.1% | Jul 31, 2022 |
| Truist Financial | Neal Dingmann | $22 | $18.2 | -30.9% | May 2, 2022 |
| Mizuho Securities | Gabriel Moreen | $22 | $19.15 | -30.9% | Apr 25, 2022 |
| Morgan Stanley | Analyst unavailable | $20 | $19.84 | -37.1% | Apr 20, 2022 |
| Morgan Stanley | Devin McDermott | $19 | $17.2 | -40.3% | Jan 30, 2022 |
| Stifel Nicolaus | Selman Akyol | $19 | $16.79 | -40.3% | Aug 2, 2021 |
| TD Securities | Linda Ezergailis | $21 | $17.6 | -34.0% | Jul 6, 2021 |
| Piper Sandler | Pearce Hammond | $19 | $17.48 | -40.3% | Jun 17, 2021 |
| Goldman Sachs | Michael Lapides | $15 | $17.98 | -52.9% | Jun 13, 2021 |
| Credit Suisse | Spiro M. Dounis | $19 | $17.43 | -40.3% | May 27, 2021 |
| Citigroup | Timm Schneider | $17 | $15.98 | -46.6% | Apr 27, 2021 |
| Neuberger Berman | Mirek Zak | $17 | $15.98 | -46.6% | Apr 27, 2021 |
Track every rating change on KMI the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationKinder Morgan, Inc. operates as a leading energy infrastructure company across North America. Its extensive operations are categorized into four primary business segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment manages a vast network of interstate and intrastate natural gas pipelines, along with underground storage systems. This includes natural gas gathering systems, processing and treatment facilities, natural gas liquids fractionation plants, transportation systems, and infrastructure for liquefied natural gas liquefaction and storage. Within its Products Pipelines segment, the company owns and operates pipelines designed for refined petroleum products, crude oil, and condensate, supported by associated product terminals and facilities for petroleum pipeline transmix.…
Historical context
All KMI earningsLatest beats and misses
Who reports nextBeat on EPS
Get the KMI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-08T07:30:43.520504+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-08T07:30:43.517446+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-08. For educational purposes only; not investment advice.